Haverford Trust CO Pfizer Inc Transaction History

Haverford Trust CO

$10.2 Billion
Q3 2024

A detailed history of Haverford Trust CO transactions in Pfizer Inc stock. As of the latest transaction made, Haverford Trust CO holds 492,217 shares of PFE stock, worth $13.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

492,217

Previous 505,118 2.55%

Holding current value

$13.1 Million

Previous $14.1 Million 0.79%

% of portfolio

0.14%

Previous 0.15%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$27.7 - $31.39 $357,357 - $404,962	-12,901 Reduced 2.55%	492,217 $14.2 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $21,268 - $24,923	842 Added 0.17%	505,118 $14.1 Million
Q1 2024 May 02, 2024	SELL	$25.89 - $29.73 $322,408 - $370,227	-12,453 Reduced 2.41%	504,276 $14 Million
Q4 2023 Feb 08, 2024	BUY	$26.13 - $33.94 $365,898 - $475,261	14,003 Added 2.79%	516,729 $14.9 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $639,649 - $747,686	-19,933 Reduced 3.81%	502,726 $16.7 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $492,785 - $570,140	-13,643 Reduced 2.54%	522,659 $19.2 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $150,863 - $196,402	3,830 Added 0.72%	536,302 $21.9 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $8,642 - $11,281	207 Added 0.04%	532,472 $27.3 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $480,353 - $586,391	10,977 Added 2.11%	532,265 $23.3 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $1.89 Million - $2.24 Million	-40,685 Reduced 7.24%	521,288 $27.3 Million
Q1 2022 May 05, 2022	BUY	$45.75 - $56.69 $819,931 - $1.02 Million	17,922 Added 3.29%	561,973 $29.1 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $27,229 - $40,363	-659 Reduced 0.12%	544,051 $32.1 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $242,054 - $310,940	6,167 Added 1.15%	544,710 $23.4 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $18.6 Million - $21.1 Million	517,454 Added 2453.67%	538,543 $21.1 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $16.4 Million - $18.6 Million	-456,740 Reduced 95.59%	21,089 $21.1 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $142,198 - $160,371	4,246 Added 0.9%	477,829 $17.3 Million
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $139,101 - $176,879	4,156 Added 0.89%	473,583 $17.4 Million
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $2,286 - $2,682	72 Added 0.02%	469,427 $17.2 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $325,898 - $395,362	-10,820 Reduced 2.25%	469,355 $15.3 Million
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $811,900 - $1.16 Million	30,037 Added 6.67%	480,175 $15.7 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $28,311 - $32,129	860 Added 0.19%	450,138 $17.6 Million
Q3 2019 Nov 04, 2019	SELL	$32.49 - $42.13 $291,695 - $378,243	-8,978 Reduced 1.96%	449,278 $16.1 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $115,451 - $129,625	3,122 Added 0.69%	458,256 $19.9 Million
Q1 2019 May 09, 2019	SELL	$37.5 - $41.2 $345,862 - $379,987	-9,223 Reduced 1.99%	455,134 $19.3 Million
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $730,352 - $832,682	-18,985 Reduced 3.93%	464,357 $20.3 Million
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $196,616 - $238,484	-5,704 Reduced 1.17%	483,342 $21.3 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $7.66 Million - $8.17 Million	-232,356 Reduced 32.21%	489,046 $17.7 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $11.2 Million - $13 Million	-350,243 Reduced 32.68%	721,402 $25.6 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $156,654 - $166,215	-4,710 Reduced 0.44%	1,071,645 $38.8 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $833,311 - $917,986	26,881 Added 2.56%	1,076,355 $38.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,049,474	1,049,474 $35.3 Million

Others Institutions Holding PFE

# of Institutions

3,224

Shares Held

3.61B

Call Options Held

77.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.

Account

Haverford Trust CO Pfizer Inc Transaction History